Systems Biology is transforming the way scientists think about biology and disease. This novel approach to research could prompt a shake up in medical science and it might ultimately allow clinicians to predict and treat complex diseases such as diabetes, heart failure, cancer, and metabolic syndrome for which there are currently no cures.
Socioeconomic position is a determinant of antiretroviral treatment effectiveness during initial therapy for HIV-1 infection. The effect was found even among subjects with high rates of drug adherence, according to a study published in the Aug. 1 issue of the Journal of Psychosomatic Research.
Vitamin D deficiency early in pregnancy is associated with a five-fold increased risk of preeclampsia, according to a study from the University of Pittsburgh Schools of the Health Sciences reported this week in the Journal of Clinical Endocrinology and Metabolism.
The Province will require 30 minutes of daily physical activity for students and is also fast-tracking the removal of junk food in schools with Canada?s most aggressive initiative yet to fight obesity in children and youth, Education Minister Shirley Bond and ActNow BC Minister Gordon Hogg announced today.
Canadian Prime Minister Stephen Harper announced the final selection of the Board of Directors for the newly created Mental Health Commission of Canada. Speaking at a gathering of international leaders in the mental health field, the Prime Minister said the selection of the new board members, as well as the chairs of the cross-country network of advisory committees, means the Commission is now formally set to launch its activities.
A partnership between Kent State University, Summa Health System and IC-MedTech Inc. has yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases.
Parents with bipolar disorder are taking part in a study that will give them the chance to follow a highly successful parenting skills program.
Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) announced that it has obtained approval to begin Phase 2 clinical testing of Provecta for the treatment of Stage III and IV metastatic melanoma, the most aggressive and deadly form of skin cancer.
A new clinical study will explore the brain-gut interaction in patients with functional dyspepsia and whether certain drugs can effectively relieve symptoms of this disorder. Functional dyspepsia is a costly and chronic disorder that can cause severe stomach pain often reported as cramping, bloating and gas, or great discomfort or fullness after eating. The study is funded by the National Institutes of Health at six medical centers in the US.
Hepatitis C Virus (HCV) infects up to 500,000 people in the UK alone, many of the infections going undiagnosed. It is the single biggest cause of people requiring a liver transplant in Britain. Now, in a collaborative effort with groups across Europe and the USA, scientists from The University of Nottingham have found monoclonal antibodies which may be a significant step towards a vaccine.